Dystroglycan: a possible mediator for reducing congenital muscular dystrophy?
- 30 June 2007
- journal article
- review article
- Published by Elsevier in Trends in Biotechnology
- Vol. 25 (6) , 262-268
- https://doi.org/10.1016/j.tibtech.2007.04.002
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Recruitment of Dbl by Ezrin and Dystroglycan Drives Membrane Proximal Cdc42 Activation and Filopodia FormationCell Cycle, 2007
- Dystroglycan: from biosynthesis to pathogenesis of human diseaseJournal of Cell Science, 2006
- The dystroglycan complex: From biology to cancerJournal of Cellular Physiology, 2005
- A simplified laminin nomenclatureMatrix Biology, 2005
- Dystroglycan: important player in skeletal muscle and beyondNeuromuscular Disorders, 2005
- The Structure of the N-terminal Region of Murine Skeletal Muscle α-Dystroglycan Discloses a Modular ArchitecturePublished by Elsevier ,2004
- Molecular Recognition by LARGE Is Essential for Expression of Functional DystroglycanCell, 2004
- Post-translational disruption of dystroglycan–ligand interactions in congenital muscular dystrophiesNature, 2002
- Structural Analysis of Sequences O-Linked to Mannose Reveals a Novel Lewis X Structure in Cranin (Dystroglycan) Purified from Sheep BrainJournal of Biological Chemistry, 1998
- Structures of Sialylated O-Linked Oligosaccharides of Bovine Peripheral Nerve α-DystroglycanJournal of Biological Chemistry, 1997